Explore the categories so you can find more about your search.

Categorie > Multiple Sclerosis

Multiple Sclerosis Disability May Be Accelerated By Cigarette Smoking

Categorie : Multiple Sclerosis
Persons with multiple sclerosis who smoke risk increasing the amount of brain tissue shrinkage, a consequence of MS, and the subsequent severity of their disease, new research conducted at the Buffalo Neuroimaging Analysis Center (BNAC) at the University at Buffalo has shown. [click link for full ar ...

read more Persons with multiple sclerosis who smoke risk increasing the amount of brain tissue shrinkage, a consequence of MS, and the subsequent severity of their disease, new research conducted at the Buffalo Neuroimaging Analysis Center (BNAC) at the University at Buffalo has shown. [click link for full ar read more Sun Oct 2007 Sun Oct 2007

How Genetic Make-Up Affects Multiple Sclerosis

Categorie : Multiple Sclerosis
Magnetic resonance images (MRI) of a large group of patients with multiple sclerosis has provided the first evidence that those with a history of MS in their families show more severe brain damage than patients who have no close relatives with the disease.The results, based on brain MRIs of 759 cons ...

read more Magnetic resonance images (MRI) of a large group of patients with multiple sclerosis has provided the first evidence that those with a history of MS in their families show more severe brain damage than patients who have no close relatives with the disease.The results, based on brain MRIs of 759 cons read more Sun Oct 2007 Sun Oct 2007

Small Study Shows Smoking May Worsen MS, UK

Categorie : Multiple Sclerosis
New research carried out at the buffalo Neuroimaging Analysis Centre at the University of Buffalo in America has shown that smoking may increase the degree of disability in people who have multiple sclerosis (MS).The study of 253 people with MS shows that smokers had significantly higher levels of d ...

read more New research carried out at the buffalo Neuroimaging Analysis Centre at the University of Buffalo in America has shown that smoking may increase the degree of disability in people who have multiple sclerosis (MS).The study of 253 people with MS shows that smokers had significantly higher levels of d read more Sun Oct 2007 Sun Oct 2007

Transformation Of Treatment Paradigm To Improve Patient Compliance With Multiple Sclerosis Therapy

Categorie : Multiple Sclerosis
The multiple sclerosis (MS) market is undergoing a revolution with the imminent introduction of innovative therapies that will change the approach toward the treatment of the disease. This market evolution has not escaped the notice of pharmaceutical and biotechnology companies across various tiers, ...

read more The multiple sclerosis (MS) market is undergoing a revolution with the imminent introduction of innovative therapies that will change the approach toward the treatment of the disease. This market evolution has not escaped the notice of pharmaceutical and biotechnology companies across various tiers, read more Sun Oct 2007 Sun Oct 2007

Scientists Show Monoclonal Antibody Leads To Repair Of Myelin Sheath In Laboratory Study Of Multiple Sclerosis

Categorie : Multiple Sclerosis
Researchers at Mayo Clinic have presented details from a preclinical study showing that a recombinant human monoclonal antibody, administered in a single low dose in a laboratory mouse model of multiple sclerosis, can repair myelin, the insulating covering over nerve fibers in the central nervous sy ...

read more Researchers at Mayo Clinic have presented details from a preclinical study showing that a recombinant human monoclonal antibody, administered in a single low dose in a laboratory mouse model of multiple sclerosis, can repair myelin, the insulating covering over nerve fibers in the central nervous sy read more Sun Oct 2007 Sun Oct 2007

Easier Access To Multiple Sclerosis Treatments Will Reduce Overall Healthcare Costs: MS Society Canada

Categorie : Multiple Sclerosis
According to the Multiple Sclerosis Society of Canada early and easy access to MS treatment options has the potential to improve quality of life and significantly reduce healthcare costs. The cost of MS to the Canadian economy is estimated to be more than 1 billion dollars per year. The commentary c ...

read more According to the Multiple Sclerosis Society of Canada early and easy access to MS treatment options has the potential to improve quality of life and significantly reduce healthcare costs. The cost of MS to the Canadian economy is estimated to be more than 1 billion dollars per year. The commentary c read more Fri Jun 2007 Fri Jun 2007

Charities Join Forces To Fight Inequalities Faced By People With MS Across EU

Categorie : Multiple Sclerosis
The UK's MS Society today joined forces with counterparts in Germany, Spain, Iceland, Poland and Romania to launch a pioneering project to map the impact of multiple sclerosis (MS) across Europe, and to fight inequalities across member states. [click link for full article] ...

read more The UK's MS Society today joined forces with counterparts in Germany, Spain, Iceland, Poland and Romania to launch a pioneering project to map the impact of multiple sclerosis (MS) across Europe, and to fight inequalities across member states. [click link for full article] read more Fri Jun 2007 Fri Jun 2007

Withdrawn MS Drug Natalizumab Reapproved By The FDA

Categorie : Multiple Sclerosis
Just months after receiving FDA approval, natalizumab, a medication for the treatment of multiple sclerosis (MS) and other inflammatory disorders, was voluntarily withdrawn by its manufacturers after three patients developed a brain infection known as Progressive Multifocal Leukoencephalopathy (PML) ...

read more Just months after receiving FDA approval, natalizumab, a medication for the treatment of multiple sclerosis (MS) and other inflammatory disorders, was voluntarily withdrawn by its manufacturers after three patients developed a brain infection known as Progressive Multifocal Leukoencephalopathy (PML) read more Thu May 2007 Thu May 2007

$5M Gift Will Attack Lou Gehrig's Disease From All Angles

Categorie : Multiple Sclerosis
Twenty years ago, retail pioneer and philanthropist A. Alfred Taubman lost a good friend to amyotrophic lateral sclerosis - a horrifying fatal disease that's better known as Lou Gehrig's disease or ALS.The memory of watching New York Sen. Jacob Javits slowly succumb to the nerve-killing condition ha ...

read more Twenty years ago, retail pioneer and philanthropist A. Alfred Taubman lost a good friend to amyotrophic lateral sclerosis - a horrifying fatal disease that's better known as Lou Gehrig's disease or ALS.The memory of watching New York Sen. Jacob Javits slowly succumb to the nerve-killing condition ha read more Tue May 2007 Tue May 2007

Unique MS Patient Database Now Widely Available

Categorie : Multiple Sclerosis
By applying to the Sylvia Lawry Centre, and on signature of a Provision of Data Agreement, authorised researchers worldwide are able to access this database. Since 2001, the Sylvia Lawry Centre for MS Research has been building the world's largest database of patient information - from 20,000+ pati ...

read more By applying to the Sylvia Lawry Centre, and on signature of a Provision of Data Agreement, authorised researchers worldwide are able to access this database. Since 2001, the Sylvia Lawry Centre for MS Research has been building the world's largest database of patient information - from 20,000+ pati read more Wed May 2007 Wed May 2007

2007 Charcot Award Winner: Professor Alastair Compston PhD, FRCP

Categorie : Multiple Sclerosis
The 2007 winner of the Multiple Sclerosis International Federation's (MSIF) prestigious biennial Charcot Award for a lifetime achievement in research into the understanding or treatment of multiple sclerosis is Professor Alastair Compston. [click link for full article] ...

read more The 2007 winner of the Multiple Sclerosis International Federation's (MSIF) prestigious biennial Charcot Award for a lifetime achievement in research into the understanding or treatment of multiple sclerosis is Professor Alastair Compston. [click link for full article] read more Wed May 2007 Wed May 2007

MS Society Responds To Daily Mail Article On MS, UK

Categorie : Multiple Sclerosis
The Daily Mail carried an article headlined, "Goggles to help MS patients walk again", featuring claims that special goggles which use sound and visual effects can help 86% of people with MS to walk faster and take longer steps. Evidence for this comes from two very small studies and improvements in ...

read more The Daily Mail carried an article headlined, read more Wed May 2007 Wed May 2007

Multiple Sclerosis Research: 2007 Charcot Award Winner: Professor Alastair Compston PhD, FRCP

Categorie : Multiple Sclerosis
I feel very honoured, and am profoundly grateful to the many colleagues who participated in our research over the last 30 years, the patients who made much of that work possible, and Multiple Sclerosis International Federation for recognising these contributions through the 2007 Charcot Award. [clic ...

read more I feel very honoured, and am profoundly grateful to the many colleagues who participated in our research over the last 30 years, the patients who made much of that work possible, and Multiple Sclerosis International Federation for recognising these contributions through the 2007 Charcot Award. [clic read more Sun May 2007 Sun May 2007

Multiple Sclerosis Research: 2007 Charcot Award Winner: Professor Alastair Compston PhD, FRCP

Categorie : Multiple Sclerosis
I feel very honoured, and am profoundly grateful to the many colleagues who participated in our research over the last 30 years, the patients who made much of that work possible, and Multiple Sclerosis International Federation for recognising these contributions through the 2007 Charcot Award. [clic ...

read more I feel very honoured, and am profoundly grateful to the many colleagues who participated in our research over the last 30 years, the patients who made much of that work possible, and Multiple Sclerosis International Federation for recognising these contributions through the 2007 Charcot Award. [clic read more Sun May 2007 Sun May 2007

Data Presented At The American Academy Of Neurology's Annual Meeting Provide Update On Utilization And Safety Of Tysabri® For Multiple Sclerosis

Categorie : Multiple Sclerosis
Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) announced today that new data from the TOUCH Prescribing Programä and TYGRIS safety study confirm the safety profile from previous clinical studies of TYSABRI® (natalizumab). [click link for full article] ...

read more Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) announced today that new data from the TOUCH Prescribing Programä and TYGRIS safety study confirm the safety profile from previous clinical studies of TYSABRI® (natalizumab). [click link for full article] read more Tue May 2007 Tue May 2007

Immediate Treatment Of Early MS Patients With Betaferon® Significantly Delayed Permanent Disability

Categorie : Multiple Sclerosis
Bayer Schering Pharma AG, Germany, announced today new data, which show that immediate initiation of Betaferon® (interferon beta-1b) treatment in patients with a first event suggestive of multiple sclerosis (MS) can significantly reduce the risk of permanent neurological impairment as measured by th ...

read more Bayer Schering Pharma AG, Germany, announced today new data, which show that immediate initiation of Betaferon® (interferon beta-1b) treatment in patients with a first event suggestive of multiple sclerosis (MS) can significantly reduce the risk of permanent neurological impairment as measured by th read more Mon May 2007 Mon May 2007

Studies Suggest Investigational Agent Reduces Disease Activity In MS

Categorie : Multiple Sclerosis
A new drug under investigation shows a reduction in disease activity in multiple sclerosis (MS), according to two studies that will be presented at the American Academy of Neurology's 59th Annual Meeting in Boston, April 28 May 5, 2007. The drug reduced disease activity as indicated by MRI scans. Bo ...

read more A new drug under investigation shows a reduction in disease activity in multiple sclerosis (MS), according to two studies that will be presented at the American Academy of Neurology's 59th Annual Meeting in Boston, April 28 May 5, 2007. The drug reduced disease activity as indicated by MRI scans. Bo read more Sat May 2007 Sat May 2007

Some MS Sufferers Can Cut Coronary Artery Disease Risk With Exercise

Categorie : Multiple Sclerosis
Multiple sclerosis (MS) is a degenerative disease affecting the central nervous system of 400,000 Americans with 200 more diagnosed each week. The disease causes reduced nerve function and consequently a variety of symptoms. The most commonly reported symptoms include muscle weakness, spasticity, ex ...

read more Multiple sclerosis (MS) is a degenerative disease affecting the central nervous system of 400,000 Americans with 200 more diagnosed each week. The disease causes reduced nerve function and consequently a variety of symptoms. The most commonly reported symptoms include muscle weakness, spasticity, ex read more Fri May 2007 Fri May 2007

Ivan Lewis MP Throws His Weight Behind Specialist Nurses - The MS Society, Epilepsy Action And Parkinson's Disease Society Welcome Backing, UK

Categorie : Multiple Sclerosis
Three neurological charities have struck a unique partnership with theDepartment of Health to support the future of the specialist nurse, whoserole has increasingly become a soft target amid health budget cuts. The MS Society, Epilepsy Action and Parkinson's Disease Society havewelcomed the backing ...

read more Three neurological charities have struck a unique partnership with theDepartment of Health to support the future of the specialist nurse, whoserole has increasingly become a soft target amid health budget cuts. The MS Society, Epilepsy Action and Parkinson's Disease Society havewelcomed the backing read more Fri May 2007 Fri May 2007

Studies Presented At Neurology Conference Highlight Early Efficacy, Long-Term Tolerability, And High Patient Satisfaction With Betaseron(R)

Categorie : Multiple Sclerosis
Bayer HealthCare Pharmaceuticals announced today the results of three clinical studies with Betaseron(R) (interferon beta-1b), presented this week at the American Academy of Neurology's (AAN) 59th Annual Meeting, demonstrating early efficacy, long-term tolerability, and high patient satisfaction wi ...

read more Bayer HealthCare Pharmaceuticals announced today the results of three clinical studies with Betaseron(R) (interferon beta-1b), presented this week at the American Academy of Neurology's (AAN) 59th Annual Meeting, demonstrating early efficacy, long-term tolerability, and high patient satisfaction wi read more Fri May 2007 Fri May 2007

<<< previous | 1 | 2 | 3 | 4 | 5 next >>>



     


Custom Search